Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF

Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J. Butte, Harold R. CollardRespirology 2019 · DOI

Abstract

Our study found no evidence that corticosteroid use improves outcomes in IPF patients admitted to the hospital with acute exacerbation. Furthermore, corticosteroid use may contribute to reduced overall survival following an exacerbation. Observational cohort studies using larger real-world cohorts can more definitively assess the relationship between corticosteroid treatment and short-term outcomes in AE-IPF.
BibTeX
@inproceedings{farrand2019corticosteroid,
  author = {Erica Farrand and Eric Vittinghoff and Brett Ley and Atul J. Butte and Harold R. Collard},
  title = {{Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF}},
  booktitle = {Respirology},
  year = {2019},
  doi = {10.1111/resp.13753},
}

Loading related content...

Figure